U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT07455916) titled 'Short-Term Effects of an AI-Based Wearable Adherence Monitor in Outpatient Psychiatry' on Feb. 25.
Brief Summary: Medication nonadherence undermines treatment effectiveness in psychiatric care, yet objective, continuous measurement in routine practice is challenging. AI-enabled wearables may offer scalable monitoring but evidence from randomized evaluations remains limited.
Study Start Date: Dec. 31, 2022
Study Type: INTERVENTIONAL
Condition:
Mental Disease
Adherence to Care
Digital Health
Intervention:
DEVICE: AI-enable smartwatch use
The device was designed to monitor medication-related behaviors in real-world settings (pil...